波兰

GROWENA IMPEX CONPANY

会员限时活动

1580 元/年

交易概况

总交易额

1,628,387.00

交易次数

13

平均单价

125,260.54

最近交易

2023/03/17

GROWENA IMPEX CONPANY 贸易洞察 (供应商)

过去5年，GROWENA IMPEX CONPANY在波兰市场展现出 近期贸易相对缓慢。 总交易额达 1,628,387.00 ，累计 13 笔交易。 平均单价 125,260.54 ，最近一次交易于 2023/03/17。

贸易记录

日期 交易公司 交易描述 数量 金额
2022-04-20 未公开 Other Cancer medicine has a circulation registration certificate: VN3-256-20; Benivatib 100mg (Imatinib Mesylat100mg); Lot: AC00222; AC00322; MFG: 03/2022; Exp: 03/2024 Manufacturer: Nobilus Ent 774.00UNA 102467.00USD
2022-01-19 未公开 Other Drugs with cancer with circulation registration: VN3-256-20; Benivatib 100mg (imatinib mesylat100mg); Lot: AC00321 (11/2021-11 / 2023) Manufacturer: Nobilus Ent 346.00UNA 60722.00USD
2022-10-12 CUU LONG PHARMACEUTICAL JOINT STOCK COMPANY Other Cancer treatment drugs with circulation registration certificates: VN3-256-20; BENIVATIB 100MG (Imatinib 100mg); Lot: AC01522; AC01622; AC01722; AC01822; AC01922;Mfg:9/22; Exp: 9/24. Manufacturer:Nobilus Ent;60 tablets/bottle 2033.00BOTTLE/BOTTLE/TUBE 255156.00USD
2022-12-10 CUU LONG PHARMACEUTICAL JOINT STOCK COMPANY Other Ca.ncer treatment drug with circulation registration certificate:VN3-256-20;BENIVATIB 100MG (Imatinib 100mg);Lot: AC02522 (10/2022-10/2024) AC02622(11/2022-11/2024); 60 tablets /bottle 766.00Bottle/Bottle/Tube 102846.00USD
2022-01-19 未公开 Other Drugs with cancer with circulation registration: VN3-257-20; Benivatib 400mg (imatinib mesylat400mg); LOT: BH00121 (11/2021-11 / 2023) Manufacturer: Nobilus ENT 747.00UNA 194214.00USD
2023-01-30 CUU LONG PHARMACEUTICAL JOINT STOCK COMPANY Other Ca.ncer treatment drugs with circulation registration certificates: VN3-256-20; BENIVATIB 100MG (Imatinib 100mg); Lot: AC00123 (01/2023- 01/2025); AC00223(01/2023- 01/2025);60 tablets/bottle 799.00Bottle/Bottle/Tube 111143.00USD

贸易国家分析

HS编码情报

HS编码 产品描述 频次
854140 光电二极管、晶体管、类似半导体器件 42
847130 便携式数字处理设备 35
851762 无线网络接入设备 28
847330 电子计算机零件 22
852910 天线和天线反射器 18
853400 印刷电路板 15